Group 1: Coal Business Overview - The company operates 11 coal production mines with an annual production capacity of 23.14 million tons, including a reserve capacity of 1.8 million tons/year [2] - Main coal products include coking coal and thermal coal, with specific mines producing high-quality environmentally friendly coal [3] - In 2025, due to insufficient downstream demand, coal consumption growth declined, leading to a downward trend in coal market prices and a decrease in overall coal sales and prices, putting pressure on the company's profitability [3] Group 2: Power Generation Business - The main operating power plant is the Baiyin Thermal Power Company, with a new unit successfully passing a 168-hour trial run in December [4] - The Qinyang Coal Power Company is responsible for a 2×660MW coal power project, currently under construction, with a planned annual output of 7 billion kWh [4] Group 3: Chemical Business - The Liu Chemical Company is developing a clean and efficient gasification project, with phase one in trial operation and phase two under construction [5] - The project utilizes coal as raw material to produce various products, including ammonia, urea, and methanol, with production capacity adjustable based on market demand [6] Group 4: Market Value Management - The company's stock price has been below the net asset value per share for 12 consecutive months, indicating a long-term undervaluation [6] - The company has disclosed a valuation enhancement plan and a shareholder return plan for 2025-2027, actively taking measures to maintain company value and return to investors [6] Group 5: Future Planning - As of the first three quarters of 2025, the company experienced cyclical losses due to declining coal prices and sales [6] - Future strategies include cost reduction, efficiency improvement, and leveraging advantages in coal production to enhance operational performance and expedite project construction [6]

Group 1: Financial Performance - The company has reduced losses in spandex compared to last year [2] - Cash flow for the year is expected to break even [2] - The operating rate in Yantai is expected to be slightly higher than in Ningxia [2] Group 2: Production and Capacity - The company is focusing on technological upgrades rather than expanding spandex production capacity [3] - There are plans for future capacity increases in aramid fibers, but specific timelines are not confirmed [3] - The production of meta-phenylene diamine is currently at 10,000 tons, with future plans for para-phenylene diamine still in the planning stage [4] Group 3: Market Dynamics - The spandex market is highly competitive, and the company aims to differentiate its products to command a premium [3] - The demand for aramid fibers is expected to grow slowly, with a focus on expanding into international markets [4] - The company is experiencing stable pricing for meta-aramid fibers, with no significant fluctuations expected in the short term [5] Group 4: Technological Development - The company is engaged in continuous technological iteration and reserves for future advancements [4] - New product developments include coatings, fireproof covers, and safety membranes, with a focus on automotive applications [6] - The company is exploring opportunities in lithium battery applications, particularly for high-performance requirements [6] Group 5: Cost Management - The company is working on reducing costs through technological improvements and efficiency enhancements [3] - The cost of aramid fibers has decreased by double digits due to advancements in technology and lower raw material prices [7] - The company is assessing existing production capacity before planning any expansions [7]

Group 1: Company Overview and Strategic Positioning - The company aims to establish a comprehensive quality assurance system covering the entire lifecycle of satellite development, production, launch, and operation, positioning itself as a leading third-party testing institution in the satellite internet sector [4] - A dedicated commercial space organization, "Tianxing Institute," has been established with over 40 professionals focusing on new technologies and standards [4] - The company has set up laboratories in major cities including Beijing, Shanghai, and Guangzhou, enhancing its service capabilities in various testing areas [4] Group 2: Financial and Investment Plans - The company plans to invest CNY 344 million (approximately USD 50 million) to build a satellite internet quality assurance platform, enhancing testing capabilities [5] - Recent revenue growth is primarily driven by four strategic sectors: reliability and environmental testing, integrated circuit testing, data science analysis, and electromagnetic compatibility testing [6][7] Group 3: International Expansion and Market Strategy - The company has made significant strides in overseas capacity layout, aligning with major clients' international strategies and expanding into Southeast Asian markets [8] - In August 2025, the company was recognized as a DV TIC certification body for toy exports, facilitating compliance testing for outbound enterprises [8] Group 4: Core Competencies in Integrated Circuits - The integrated circuit testing and analysis division serves as a core public service platform for the semiconductor industry, certified by various governmental bodies [9] - The company has developed a comprehensive testing and analysis system covering the entire semiconductor supply chain, including advanced failure analysis and process diagnostics [10] Group 5: Competitive Position and Future Outlook - The company has established core competitive advantages in special equipment, aerospace, and new energy vehicles through innovation and quality control [10] - By focusing on customer needs and leveraging core technologies, the company aims to enhance its competitiveness and support high-quality development in advanced manufacturing [10]

Group 1: Company Overview - The main business of Guilin Tourism Co., Ltd. is tourism, which includes scenic area tourism, Li River cruise passenger transport, and hotel operations [2] - Key scenic areas include: Two Rivers and Four Lakes, Silver Cave, Longsheng Hot Springs, and Fengyu Rock [2] - The company's revenue primarily comes from Li River cruise operations, Two Rivers and Four Lakes, Silver Cave, and the Li River Waterfall Hotel [2] Group 2: Development Strategy - The company aims to establish Guilin as a world-class tourist city, focusing on optimizing existing assets and expanding into ASEAN markets [2] - The strategic framework includes "one core, one optimization, two wings, and three expansions" to enhance company value [2] - One core: Strengthening the main cultural tourism business [2] - One optimization: Optimizing asset structure and divesting non-performing assets [2] - Two wings: Empowering operations through digital tourism technology and capital management [2] - Three expansions: Increasing investment in new projects, expanding cultural tourism, and enhancing brand output [3] Group 3: Key Initiatives - The company will implement three major measures: "preserving volume, expanding volume, and shedding burdens" to drive high-quality development [3] - Preserving volume includes leveraging AI for new tourism experiences and enhancing existing attractions with technology [3] - Expanding volume involves exploring new tourism consumption avenues and developing integrated tourism products [3] - Shedding burdens focuses on optimizing and revitalizing underperforming assets through tailored strategies [3] Group 4: Financial Management - The company is committed to improving its financial structure by actively managing accounts receivable and enhancing cash flow [3] - A special collection team will be established to recover outstanding debts, providing more operational flexibility [3] Group 5: Industry Collaboration - The company welcomes industry institutions to propose effective measures for improving its fundamentals and to participate in collaborative efforts [4]

Group 1: Company Overview - The company focuses on the Internet of Things (IoT) sector, particularly in RFID technology, and is exploring new consumer markets, specifically the pet economy [3][6]. - The company aims to leverage its RFID expertise to establish a competitive edge in the pet economy, which is currently in the investment phase [3][7]. Group 2: Financial Performance - In the first three quarters of 2025, the company achieved a revenue of ¥417,703,884.71, reflecting a year-on-year growth of 11.16% [8]. - The company’s financial data indicates strong performance over the past two years, although the core business has faced challenges post-deduction of non-recurring items [3][8]. Group 3: Business Strategy - The company employs a dual strategy of organic growth and external acquisitions to enhance its business development [6][10]. - The pet economy segment is expected to become the company's second growth curve, with a focus on solidifying market presence and validating business models [7][10]. Group 4: Market Trends and Challenges - The growth of the pet economy is driven by increasing societal demand for pet companionship and the rising penetration of smart devices in this sector [9][10]. - The company is committed to ensuring data security in RFID technology, addressing potential threats through established legal frameworks and internal policies [3][4]. Group 5: Future Outlook - The company is actively monitoring industry merger and acquisition policies to align its strategic investments with its core business objectives [10]. - The long-term vision includes fostering a robust ecosystem within the IoT industry to achieve sustainable growth and operational synergy [10].

阜新德尔汽车部件股份有限公司投资者关系活动记录表 证券代码：300473 证券简称：德尔股份 编号：2025-009 | | ■特定对象调研 □分析师会议 | | --- | --- | | 投资者关系活 动类别 | □媒体采访 □业绩说明会 | | | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他 （请文字说明其他活动内容） 民生证券：裴婉晓 海通证券：潘一忻 | | | 国盛证券：林卓欣 信达证券：赵启政 | | | 东方财富证券：朱晋潇 长城证券：金瑞 | | 参与单位名称 | 财通证券：王思宁 国元证券：陈烨尧 | | 及人员姓名 | 南京证券：张儒成 东方证券：何雨蒙 | | | 永唐盛世：吴小超 大筝资管：徐海涛 | | | 兖矿资本：王彦芳、张国梁 熙锦汇投资：刘莹 | | | 允朗投资：查桢伟 弘君基金：周广可 | | 时间 | 2025 年 12 月 25 日 | | 地点 | 德尔股份上海分公司会议室 | | 上市公司接待 人员姓名 | 董事会秘书：张磊 | | 投资者关系活 | Q1、公司 2025 年前三季度经营情况？ | | | 2025 年前三季度，公司实现 ...

Group 1: Company Overview and H Share Listing Progress - The company has submitted an application for H share listing on the Hong Kong Stock Exchange, with the application materials published on the same day [3] - The China Securities Regulatory Commission has provided initial feedback on the application, and the company is actively responding to these comments [3] - The timeline for the listing process will depend on the review progress by the regulatory authorities [3] Group 2: ficonTEC's Role and Market Trends - ficonTEC is a leading manufacturer in the field of photonics and semiconductor automation, collaborating closely with top global clients [4] - The demand for optical modules is expanding, leading clients to initiate large-scale production plans, with a shift towards higher-speed products [4] - The complexity of assembly and testing is increasing, making fully automated manufacturing models more valuable compared to traditional manual methods [4] Group 3: Capacity and Production Planning - The company is preparing to enhance its capacity to meet the rapid market growth and client forecasts [6] - Plans include leveraging the restructuring of the company to improve team efficiency and talent in key areas such as design and assembly [6] - The company aims to support capacity expansion through financing from the Hong Kong stock market and optimize the supply chain [6] Group 4: CPO Industry Development - The CPO industry's rollout is progressing normally, contrary to market rumors of a slowdown, with the company’s operations and production schedules remaining on track [8] - Downstream clients are accelerating the delivery process, which is driving the company to enhance its production capacity [8] Group 5: Equipment Line Value and OCS Collaboration - The company cannot disclose specific values for equipment lines due to design variations and commercial confidentiality [9] - Collaboration in the OCS technology path has been established with key industry participants, including providing automation equipment for a Swiss client [9]

Group 1: Company Overview and Market Position - The company has established partnerships with major domestic clients and is actively expanding into international markets [1][2] - The 200G and below low-speed optical modules have achieved stable mass production, while 400G/800G high-speed modules are in the sample testing phase with expected small batch shipments in Q2 2026 [1][2] Group 2: Strategic Development and Capacity Expansion - The company adopts a customer demand-driven approach for capacity expansion, focusing on small batch production to explore market needs before scaling up [3] - A stepwise development strategy is employed, starting with mature products to build customer resources and industry experience before moving to high-value products [3] Group 3: Importance of 200G and Below Optical Modules - The decision to prioritize 200G and below optical modules is based on their strong demand stability and significant economies of scale, which enhance market competitiveness [5] - Stable mass production of these modules supports the development of high-speed module production lines and improves overall operational efficiency [5] Group 4: Core Competencies and Innovations - The company has strong capabilities in scaling production and converting laboratory technologies into market-ready products, which benefits the optical communication business [6] - Emphasis on innovation and cost structure optimization through continuous process improvements and automation enhances competitive advantages [7] Group 5: Micro LED Technology Strategy - The Micro LED optical interconnect technology addresses key issues in high bandwidth and high-speed scenarios, positioning the company for long-term growth in optical communication [8][10] - Current focus is on achieving breakthroughs in core light source technology and building intellectual property barriers for future industrialization [10] Group 6: Smart Terminal Business Outlook for 2026 - The smart terminal business is expected to recover in 2026 due to global layout strategies, automation improvements, and diversification of product offerings [10]

Group 1: Competitive Advantages in Overseas Operations - The company has over 40 years of experience in overseas operations, with projects in more than 100 countries and regions, establishing a core competitive advantage through a differentiated competition strategy [3] - It has set up over 70 overseas offices, focusing on traditional markets in Southeast Asia, South Asia, the Middle East, Central Asia, and Latin America, while also expanding into new markets like Guyana and Nicaragua [3] - The company emphasizes high-standard, sustainable projects that can stimulate local economies and create jobs, targeting projects with high technical barriers and good payment capabilities [3] - A diversified financing model supports project implementation, backed by stable cash flow and a good debt-to-asset ratio [3] - The company integrates ESG principles into its strategy, enhancing its position as an industry leader in sustainable development [3] Group 2: Overseas Investment Plans and Layout - During the 14th Five-Year Plan, the company aims to cover environmental engineering, clean energy engineering, and cableway engineering, transitioning to an integrated investment and operation model [4] - Two waste-to-energy projects in Uzbekistan have been initiated with a total investment of approximately $475 million, expected to yield a post-tax internal rate of return of no less than 8% [5] - The company has increased its wastewater treatment capacity to 280,000 tons per day, positioning itself within the medium scale of the industry [5] Group 3: Core Technologies - The company aims to become a technology-driven professional engineering firm, leveraging its international business development network and financing advantages [6] - It has established over 70 overseas branches and has a professional international operation and financing team [6] - The company is involved in high-value sectors such as healthcare, digital infrastructure, airport logistics, and energy engineering, supported by strong design and manufacturing capabilities [6] - It has participated in the formulation of numerous international and national standards, receiving over a thousand awards at various levels [6] Group 4: Future Outlook and Strategic Goals - The company has set a strategic goal to enhance the quality of the listed company, focusing on transformation, integration, and high-quality development [6] - It aims to improve its engineering value chain and core competitiveness while better serving national strategies and focusing on industrialization [6] - The company plans to transition its business layout towards high-end manufacturing and international operations [6] Group 5: Market Value Management - The company maintains a high dividend policy, ensuring cash dividends are no less than 40% of the distributable profits for the year [7] - It has received the highest A-level rating from the Shenzhen Stock Exchange for 15 consecutive years, indicating strong disclosure quality [7] - The company has allocated between 50 million to 100 million yuan for share repurchases, with 550,000 shares already repurchased as of December 1 [7]

Group 1: Product Performance and Market Strategy - The patent protection for the injectable form of Esomeprazole will last until after 2035, while the tablet form has faced generic competition in China, yet the company has maintained stable sales growth in the first three quarters of this year due to its strong presence in the gastrointestinal sector [2] - The P-CAB product JP-1366 is expected to participate in the 2027 medical insurance negotiations, with sales anticipated to ramp up significantly after its market entry [2][3] - The domestic sales of P-CAB products reached approximately CNY 1.45 billion in the first three quarters of 2025, representing a year-on-year growth of 65% [3] Group 2: Competitive Landscape in Mental Health Treatments - The average usage rate of long-acting antipsychotic injections in Europe and the U.S. is between 25%-30%, while the rate in China is currently below 1% [3] - The new guidelines for schizophrenia treatment emphasize the importance of long-acting therapies, which is expected to increase the market penetration and sales of the company's long-acting antipsychotic products [3][4] - The company strategically focuses on developing third-generation antipsychotic drugs for long-acting formulations to avoid safety issues associated with first- and second-generation drugs [4] Group 3: Pipeline and Future Developments - The IL-17A/F monoclonal antibody (LZM012) has been submitted for regulatory approval and is expected to participate in the 2027 national medical insurance negotiations [5] - The recombinant human follicle-stimulating hormone (r-FSH) is set to launch in 2026, enhancing the company's product matrix in assisted reproduction [5][6] - The company has significantly reduced losses this year and anticipates entering a product harvest phase with the upcoming launches of r-FSH and LZM012 [6]